Belzutifan plus cabozantinib combination shows promise in advanced kidney cancer
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
Promising new combination therapy for advanced kidney cancer
Combinations of tyrosine kinase inhibitors plus immunotherapy have improved treatment [...]
NHS England’s Elective Care Reform Plan
On 6 January 2025, NHS England launched their plan to [...]
FDA approves injectable form of nivolumab
Just after Christmas, the US Food and Drug Administration (FDA) [...]
NHS Help Us, Help You campaign
We know that many people worry about cancer but sometimes [...]
NHS National Cancer Patient Experience Survey
The NHS National Cancer Patient Experience Survey (NCPES) aims to [...]
Promising new immunotherapy combination for advanced kidney cancer
The first results from a phase 2 study (FRACTION-RCC) looking [...]
New treatment for pretreated advanced kidney cancer shows promise
A new treatment, called NDI-101150 has been shown to be [...]
Cancer waiting times – latest updates
Pressure on NHS cancer services has been mounting over the [...]
The Big Cancer52 Conversation
Earlier this week, Sharon Deveson Kell represented kidney cancer patients [...]
